ARS Responds to Critical National Drug Shortage
During Hurricanes Maria and Harvey, Pharmaceutical and Medical Device manufacturers in Puerto Rico sustained damage to their manufacturing plants. This damage has primarily impacted the production of 50mL and 100mL IV fluids resulting in a national shortage. ARS is working with its clients to provide solutions through alternative methods of delivering optimal antimicrobial therapy, such as utilizing IV push, continuous infusion, route optimization, and dosing protocols. Due to predictions that the shortage will not resolve quickly, ARS will be continually evolving its approach based on changes with the shortage and its impact.
Antimicrobial Resistance Solutions
Antimicrobial Resistance Solutions (ARS) redefines antimicrobial stewardship by delivering customized, nimble antimicrobial management programs for hospitals, healthcare systems, Accountable Care Organizations and long-term care facilities. Designed by physicians and clinical pharmacists, the program links prescribers to up-to-date antimicrobial prescribing and resistance prevention theory.
ARS Stewardship Program
The ARS Stewardship Program includes a comprehensive assessment, in-depth training and education for the clinical pharmacists, physician engagement, online support and education, and program results reporting and benchmarking.
ARS provides access to critical resources including media, case studies, and publications on both the provider and community level. ARS recognizes the need to deliver results and updated information in order to have a greater impact on antibiotic resistance and improve patient care.